Guy de Laroche

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial

C. Carrié, Ali Hasbini, Guy de Laroche et al. · The Lancet Oncology · 2016 · 361 citations

Medicine, Oncology, Urology +15

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity

Adeline Granzotto, Mohamed Amine Benadjaoud, Guillaume Vogin et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 122 citations

Medicine, Molecular Biology, Oncology +17

A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice

Isabelle Ray‐Coquard, Thierry Philip, Guy de Laroche et al. · British Journal of Cancer · 2002 · 102 citations · Full text

Medicine, Oncology, Breast Oncology +6

Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial

Jean‐Pierre Gérard, Emmanuel Chamorey, S. Gourgou-Bourgade et al. · Radiotherapy and Oncology · 2015 · 81 citations

Medicine, Oncology, Surgery +17

Persistence of Medical Change at Implementation of Clinical Guidelines on Medical Practice: A Controlled Study in a Cancer Network

Isabelle Ray‐Coquard, Thierry Philip, Guy de Laroche et al. · Journal of Clinical Oncology · 2005 · 64 citations · Full text

Law, Oncology, Cancer Control +13